Bristol-Myers Squibb Co (NYSE:BMY) Position Trimmed by Spinnaker Trust

Leslie Hanson
January 13, 2018

The firm has a market cap of $102,240.00, a PE ratio of 24.59, a P/E/G ratio of 2.22 and a beta of 1.18. The institutional investor held 135,181 shares of the consumer electronics and appliances company at the end of 2017Q3, valued at $3.07M, down from 151,000 at the end of the previous reported quarter. Excalibur Management Corp now owns 17,765 shares of the biopharmaceutical company's stock valued at $1,132,000 after buying an additional 3,420 shares during the period.

Taking notice on volatility measures, price volatility of stock was 1.36% for a week and 1.45% for a month. Arrowstreet Capital Limited Partnership reported 5.08M shares. Unilever PLC (NYSE:UL) has risen 20.68% since January 11, 2017 and is uptrending. It has underperformed by 39.89% the S&P500. Bristol-Myers Squibb Co has a 12 month low of $46.01 and a 12 month high of $66.10. Aviance Capital Management Llc sold 28,252 shares as the company's stock declined 1.04% while stock markets rallied. The hedge fund run by Frank Brosens held 35,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.23M, down from 50,000 at the end of the previous reported quarter. That's a potential 2.29 increase relative to where Bristol-Myers Squibb Company (NYSE:BMY) has been trading recently. About 557,006 shares traded or 23.03% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 11, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Investors sentiment increased to 1.03 in 2017 Q3. Its down 0.10, from 0.79 in 2017Q2.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Sphera Funds Management LTD. bought a new stake in Bristol-Myers Squibb during the first quarter valued at $8,157,000.

Bristol-Myers Squibb Co (NYSE:BMY) opened at $62.47 on Friday. Amalgamated Savings Bank holds 0.38% or 193,806 shares in its portfolio. Old Natl Commercial Bank In owns 87,268 shares. Argi Inv Ltd Liability Corp has invested 0.02% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Bar Harbor Trust accumulated 9,639 shares or 0.33% of the stock. Millennium Mgmt Ltd Liability holds 4,122 shares. Srb invested in 3,111 shares or 0.03% of the stock. Sei Invs Co holds 0.13% or 581,758 shares. Bridges Invest Management has 14,214 shares.


Since January 1, 0001, it had 1 buying transaction, and 2 sales for $646,385 activity. Lynch sold 5,300 shares of the stock in a transaction that occurred on Tuesday, December 12th. Shares for $560,400 were sold by Caldarella Joseph C.

The collective rating of 2.4 for Bristol-Myers Squibb Company (NYSE:BMY) also leans strongly towards the neutral end of the spectrum. Therefore 40% are positive. The original version of this piece can be read at https://registrarjournal.com/2018/01/12/lipe-dalton-increases-position-in-bristol-myers-squibb-co-bmy.html. The rating was initiated by Hilliard Lyons on Monday, May 23 with "Neutral". The Stock shows P/E value of 14.23 and Forward P/E of 14.57. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. UBS maintained the stock with "Buy" rating in Friday, August 19 report. This is a boost from Bristol-Myers Squibb's previous quarterly dividend of $0.39. Stifel Nicolaus has "Buy" rating and $179.0 target. The firm has "Hold" rating by Jefferies given on Thursday, November 16. On Wednesday, October 11 the stock rating was maintained by KeyBanc Capital Markets with "Buy". The firm earned "Buy" rating on Monday, July 17 by Jefferies. It also increased its holding in Matador Res Co (NYSE:MTDR) by 41,130 shares in the quarter, for a total of 121,765 shares, and has risen its stake in Sei Investments Co (NASDAQ:SEIC).

Since July 31, 2017, it had 0 buys, and 8 selling transactions for $6.48 million activity. Sadler Jason D sold $6.65M worth of stock. (NASDAQ:CSCO) for 1.14 million shares. (NASDAQ:FSLR) to report earnings on February, 20. The biopharmaceutical company reported $0.75 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.77 by ($0.02).

Cliftonlarsonallen Wealth Advisors LLC purchased a new position in Bristol-Myers Squibb Company (NYSE:BMY) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.

Investors sentiment decreased to 1.22 in 2017 Q3. Earnest Partners stated it has 1.15 million shares or 0.66% of all its holdings. It worsened, as 60 investors sold SHW shares while 210 reduced holdings. 28 funds opened positions while 87 raised stakes. 25,871 were accumulated by Investec Asset Mngmt Limited. Vanguard accumulated 121.79 million shares. (NYSE:AIN). Kennedy Cap Management Incorporated owns 240,548 shares. Wilkins Investment Counsel reported 0.08% stake. Franklin Resources Inc. raised its position in shares of Bristol-Myers Squibb by 185.2% during the 2nd quarter. 842,880 are owned by Rnc Capital Limited Liability Com. Harris Associates Lp invested in 0.04% or 391,881 shares. Rockefeller Financial Svcs has invested 0.28% in Cisco Systems, Inc. (NASDAQ:CSCO). Lincluden Ltd reported 439,526 shares. 86,385 are held by Town Country Bank Trust Dba First Bankers Trust. Nationwide Fund Advsrs, a Pennsylvania-based fund reported 248,843 shares. 36,635 were reported by First Quadrant Lp Ca. Therefore 65% are positive. Petroleo Brasileiro Petrobras SA had 37 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Northland Capital on Wednesday, August 2 with "Hold". As per Thursday, July 27, the company rating was maintained by Leerink Swann. Piper Jaffray maintained Intersect ENT, Inc. The firm has "Hold" rating given on Friday, July 21 by CFRA. Cowen & Co has "Buy" rating and $57.0 target. UBS maintained the shares of BMY in report on Friday, August 19 with "Buy" rating. On Thursday, August 11 the stock rating was downgraded by Berenberg to "Hold". The company was downgraded on Wednesday, August 12 by Goldman Sachs. JMP Securities upgraded the stock to "Market Outperform" rating in Wednesday, May 24 report. The company was downgraded on Thursday, May 18 by Robert W. Baird.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER